ACE2 News and Research

RSS
Scientists are developing synthetic COVID-19 antibody to treat sick patients

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Research looks at best ways to tackle coronavirus crisis

Research looks at best ways to tackle coronavirus crisis

SARS-CoV-2 targets specific cells in the lung, nasal passage, and intestine

SARS-CoV-2 targets specific cells in the lung, nasal passage, and intestine

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

RAS inhibitors and COVID-19 severity in hypertensive patients

RAS inhibitors and COVID-19 severity in hypertensive patients

Study identifies key nose cells as likely COVID-19 virus entry points

Study identifies key nose cells as likely COVID-19 virus entry points

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

Scientists identify cells likely targeted by novel coronavirus

Scientists identify cells likely targeted by novel coronavirus

COVID-19 unlikely to be transmitted through semen, study shows

COVID-19 unlikely to be transmitted through semen, study shows

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

Research offers clues to how SARS-CoV-2 gets into respiratory tissue and exploits our defenses

Role of ACE/ARB inhibitors in the treatment of COVID-19

Role of ACE/ARB inhibitors in the treatment of COVID-19

ACE2 receptor expression by SARS-CoV-2 across different animal species

ACE2 receptor expression by SARS-CoV-2 across different animal species

Mutations in novel coronavirus make it more dangerous

Mutations in novel coronavirus make it more dangerous

ACE2-TMPRSS2 profiling indicates tissue vulnerability to SARS-CoV-2 infection

ACE2-TMPRSS2 profiling indicates tissue vulnerability to SARS-CoV-2 infection

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

Novel coronavirus mutation could spell trouble for vaccine development

Novel coronavirus mutation could spell trouble for vaccine development

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

Delayed clearance of SARS-CoV2 may explain why men fare worse than women

Delayed clearance of SARS-CoV2 may explain why men fare worse than women

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

Supercomputer helps find 64 compounds as potential inhibitors of the COVID-19 protease

Researchers design peptide inhibitors for potential COVID-19 treatments

Researchers design peptide inhibitors for potential COVID-19 treatments